GSK, Teva Can't Put Brakes On Pay-For-Delay Challenge

Law360, New York (October 24, 2012, 4:42 PM EDT) -- GlaxoSmithKline PLC and Teva Pharmaceutical Industries Ltd. on Tuesday failed to pause class action allegations that they conspired to keep a generic drug off the market, after a New Jersey federal judge said the U.S. Supreme Court wasn't likely to pick up a similar case potentially affecting the instant suit.

U.S. District Judge William H. Walls denied the pharmaceutical companies' bid to stay a case in which GSK and Teva face allegations they reached a "pay-for-delay" settlement preventing the release of a generic version of GSK's...
To view the full article, register now.